Satomi Kagota
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 19, 2026
Vasomotor Function and Its Modulation by Perivascular Adipose Tissue Vary Depending on Metabolic Syndrome Stage.Satomi Kagota, Kana Maruyama-Fumoto, Aya Niki
|Sep 02, 2024
Functional anticholinergic activity of drugs classified as strong and moderate on the anticholinergic burden scale on bladder and ileum.Satomi Kagota, Risa Futokoro, Kana Maruyama-Fumoto
|Jul 27, 2022
Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters.Satomi Kagota, Risa Futokoro, John J McGuire
|Mar 25, 2021
A Sodium Glucose Cotransporter 2 Inhibitor Fails to Improve Perivascular Adipose Tissue-Mediated Modulation of Vasodilation and Cardiac Function in Rats With Metabolic Syndrome.Satomi Kagota, Kana Maruyama-Fumoto, John J McGuire
|Oct 30, 2020
Activation of protease-activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome.Kana Maruyama-Fumoto, John J McGuire, David P Fairlie
|Aug 18, 2019
Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome.Satomi Kagota, Kana Maruyama-Fumoto, Miho Shimari
Pageof 2
